What is Xarelto?
Xarelto is an anticoagulant containing the active ingredient rivaroxaban that was released onto the United States market after it was approved by the Food and Drug Administration (FDA) in 2011. The drug was developed by Bayer AG and released in the United States by Janssen Pharmaceuticals, the pharmaceutical unit of Johnson&Johnson. Since its release, Xarelto’s manufacturers have embarked on an intense marketing campaign around the drug, pushing the theory that it is more convienent than other blood thinners on the market with its ‘one size fits all’ method of dosing and
Why is Xarelto More Dangerous?
Xarelto is more dangerous than traditional blood thinners due to the way that it works. As explained above, Xarelto is a Xa inhibitor, which completely takes away the blood’s ability to clot. This is problematic because there is no antidote to the effects of the drug. If a patient taking Xarelto suffers from an internal bleeding event, there is no available antidote to reverse the effects of Xarelto and stop the bleeding. If a patient is taking a more traditional blood thinner such as Warfarin, a doctor can administer vitamin K in an emergency situation and the blood will be able to clot again. Xarelto’s lack of an antidote is what makes it so dangerous and can cause serious injury in patients who are taking the drug. Recent Xarelto lawsuits allege that Xarelto’s manufacturers were aware of this danger and concealed the information from doctors and patients.
Xarelto currently has two ‘Black Box’ warnings attached to it by the FDA. The Black Box warning is the most strict warning the FDA can attach to a drug short of recalling it. For more information on the warnings the FDA has released in regards to Xarelto, click here.
Internal Bleeding Incidents in Montana
Using known data available to us, our team has been able to estimate the number of Montana residents who may have been injured by Xarelto. By comparing the population of Montana at the time of the 2010 U.S. Census to the instance rate of internal bleeding incidents linked to Xarelto across the entire United States, we are able to estimate how many people in Montana may have been injured by Xarelto. We are also able to use this formula to break it down by Montana’s top five most populous cities. The population of Montana in 2010 was 989,415 and we can estimate that there are 35,250 Montana residents who are taking or have taken Xarelto. We estimate that there are 600 Montana residents across the entire state who have experienced an internal bleeding injury that may have been caused by their Xarelto usage. Here is the data broken down by Montana’s largest cities:
Population of Montana’s Largest Cities
- Billings – 104,170
- Missoula – 66,788
- great falls – 58,505
- Bozeman – 37,280
- Butte – Silver – 33,525
Number of Internal Bleeding Incidents in Montana’s Largest Cities
- Billings – 63
- Missoula – 40
- Great Falls – 35
- Bozeman – 22
- Butte Silver – 20
Xarelto Victims in Montana Are Filing Lawsuits
If you or a loved one are residents of Montana and have been injured in Xarelto, there are options available to you. Xarelto victims all over the country are filing lawsuits against the manufacturers of Xarelto, Bayer AG and the pharmaceuticals unit of Johnson&Johnson, Janssen Pharmaceuticals, alleging that the manufacturers knew about the dangers of the drug and deliberately concealed them from patients and doctors.
The lawyers at Osborne & Associates are very experienced in standing up to large pharmaceutical companies and will fight for your rights and justice. If you feel that you have been injured by your Xarelto usage, contact us for a free consultation and case evaluation. Filing a lawsuit to hold the manufacturers responsible for their negligence can help you find closure and gain compensation for the expenses, loss of wages, and pain and suffering that you have experienced because of your injury. If a loved one had taken Xarelto and tragically passed away from your injuries, survivors of the deceased also have rights to file wrongful death lawsuits. For more information about Xarelto lawsuits, visit our website here.